India Bioreactors Market to 2025
No of Pages: 99 Published: Apr 2019 Single User PDF: US$ 3000
Website : www.premiummarketinsights.com
India Bioreactors Market to 2025
Introduction
The India bioreactors market is expected to reach US$ 164.8 Mn in 2027 from US$ 94.6 Mn in 2018. The market is estimated to grow with a CAGR of 6.6% from 2019-2027. The growth of the bioreactors market is primarily attributed to the increasing number of bioreactors manufacturers, speedy evolution of pharmaceutical industry and aggressive pharmaceutical & biotechnological activities. However, concern of regulatory framework is likely to hinder the growth of the market during the forecast period. Additionally, the growth of the India bioreactors market is contributed by factors such as opportunities to develop personalized medicine. India is counted among the emerging nations where the biotechnology and pharmaceutical industry is growing rapidly. According to the Department for Promotion of Industry and Internal Trade Indian biotechnology industries is among the top 12 biotech destinations in the world and ranks third in the Asia Pacific. The country has the second highest number of the USFDA approved plants. In addition, approximately 104 new startups, 346 companies, 509 projects including 115 collaborative projects are being supported by the BIRAC, a Public Sector Unit of Government of India. Thus, the above mentioned factors are driving the growth of the India bioreactors market and is expected to continue in the future.
View Complete Report @ https://www.premiummarketinsights.com/reports-tip/india-bioreactorsmarket Contact Us : +1-646-491-9876| E-Mail : sales@premiummarketinsights.com
India Bioreactors Market to 2025
The advancement in the industry has made the Indian pharmaceutical industry to hold highest number (approximately 3,950) of Drug Master Files (DMFS) with USFDA by the end of 2016. In addition, it was expected that India's Abbreviated New Drug Applications (ANDAS) will have approximately 4,000 application by June 2017. According to the Department for Promotion of Industry and Internal Trade (Make in India) statistics the growth of the pharmaceuticals industry has earned approximately USD 16.8 billion from the exports of its API, generic and others medicinal products in between 2016-2017. Therefore, owing to these factors the pharmaceutical industry require higher number of the bioreactors for drug manufacturing. Thus, the increasing demand of the pharmaceutical products are leading to the growth of the bioreactors in India.
Request for Discount @ https://www.premiummarketinsights.com/discount/TIP00010356 Contact Us : +1-646-491-9876| E-Mail : sales@premiummarketinsights.com
India Bioreactors Market to 2025 Companies Mentioned 1. Thermo Fisher Scientific Inc. 2. Applikon Biotechnology BV 3. Merck KGaA 4. Sartorius AG 5. Eppendorf 6. General Electric 7. Bioengineering AG 8. Solaris Biotechnology Srl 9. Danaher (Pall Corporation) 10. Praj Industries 11. DDE 12. BiOZEEN 13. Biotree 14. Zeta Holding GmbH
Inquire Before Buying @ https://www.premiummarketinsights.com/inquiry/TIP00010356 Contact Us : +1-646-491-9876| E-Mail : sales@premiummarketinsights.com
India Bioreactors Market to 2025
In 2017, the industrial scale (>1000L) bioreactors segment held a largest market share of 63.6% of the bioreactors market, by product. This segment is also expected to dominate the market in 2027 owing to increasing demand for industrial scale (>1000L) bioreactors in pharmaceutical companies. However, the pilot scale (15 - 1000L) bioreactors segment is anticipated to witness the fastest growth rate of 7.1% during the forecast period, 2019 to 2027 owing to the increased use of pilot scale bioreactors for research purposes. Microbial application segment is anticipated to grow at a CAGR of 6.9% during the forecast period. The production of microbiologic and increasing government funding as well as promotional initiatives undertaken for usage of microbial products to treat medical conditions. Increasing R&D innovation in various other microbial applications has also been contributing significantly to the growth of the bioreactors market. Some of the major primary and secondary sources for bioreactors included in the report are Abbreviated New Drug Applications (ANDAS), Department for Promotion of Industry and Internal Trade (Make in India), World Health Organization, Indian Drug and Pharmaceutical Limited, National Institutes of Pharmaceutical Education & Research (NIPERs) and others.
Request Sample Copy @ https://www.premiummarketinsights.com/sample/TIP00010356 Contact Us : +1-646-491-9876| E-Mail : sales@premiummarketinsights.com
About Us Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
Contact Us : +1-646-491-9876| E-Mail : sales@premiummarketinsights.com